Tag : HEALTH-RELATED QUALITY OF LIFE

NEWS AND PERSPECTIVE

Multicomponent intervention including CBT improves QoL in women with overactive bladder
Overactive bladder (OAB) is a chronic condition characterized by urinary urgency, frequency, and nocturia, with or without urgency incontinence.1,2 It is estimated to affect 10%-20% of women, with higher incidence and more severe symptoms observed among older individuals.
CONFERENCE UPDATE

Long-term HRQoL outcomes of dostarlimab + chemotherapy in patients with primary advanced or recurrent EC from the RUBY trial
Dostarlimab in conjunction with carboplatin-paclitaxel (CP) has previously been shown to significantly improve progression-free survival (PFS) and overall survival (OS) outcomes compared with CP alone in patients with primary advanced or recurrent endometrial cancer (EC).1 This has led to its approval in the first line for EC patients in the mismatch repair deficient (dMMR) microsatellite instability-high (MSI-H) population. However, more data are required to describe the health-related quality of life (HRQoL) of this immunotherapy CP combination over extended periods.
CONFERENCE UPDATE

HRQoL improvements with pembrolizumab + CCRT and EBRT in high-risk LACC patients in ENGOT-CX11/GOG-3047/KEYNOTE A18